Metformin promotes smear conversion in tuberculosis‐diabetes comorbidity and construction of prediction models-Reference-Cited by-同舟云学术

Metformin promotes smear conversion in tuberculosis‐diabetes comorbidity and construction of prediction models

Published:2022-11-08 Issue:12 Volume:36 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:Clinical Laboratory Analysis

Author:

Wang Yili¹²,Zhou Yanbing¹²,Chen Liyu³,Cheng Yuhui¹²,Lai Hongli¹²,Lyu Mengyuan¹²,Zeng Jiongjiong⁴,Zhang Yao⁴,Feng Ping³,Ying Binwu¹²^ORCID

Affiliation:

1. West China Hospital Sichuan University Chengdu China

2. West China School of Medicine Sichuan University Chengdu China

3. Center for Infectious Diseases West China Hospital, Sichuan University Chengdu China

4. Ganzi People’s Hospital Ganzi Prefecture China

Funder

National Science and Technology Entrepreneurship Development Board

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.24755

Reference36 articles.

1. Tuberculosis and diabetes mellitus: convergence of two epidemics

2. The re-emerging association between tuberculosis and diabetes: Lessons from past centuries

3. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis

4. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis

5. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting Metformin Efficacy in Improving Insulin Sensitivity Among Women With Polycystic Ovary Syndrome and Insulin Resistance: A Machine Learning Study;Endocrine Practice;2024-08

2. The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds;Frontiers in Microbiology;2024-06-20